Figure 2.

All patients received induction with basiliximab and maintenance therapy with mycophenolate mofetil and corticosteroids.

Notes: Patients randomized to receive cyclosporine were started at 7 ± 3 mg/kg daily in divided doses with a goal trough of 150–300 ng/mL for the first month followed by 100–250 ng/mL thereafter. MI-treated patients received belatacept at 10 mg/kg for the first 168 days and 5 mg/kg from day 196 onwards. LI-treated patients received belatacept at 10 mg/kg for the first 84 days and 5 mg/kg from day 112 onward. *All patients received basilixmab induction, mycophenolate mofetil, and corticosteroid-taper.